Walnuts for Anti-Inflammatory

Research suggests that walnuts contain a collection of bioactive compounds — including alpha-linolenic acid (ALA), polyphenols such as ellagitannins, vitamin E, and fiber — that may collectively support anti-inflammatory activity through several biological pathways, including gut microbiome modulation, reduced oxidative stress, and suppression of key inflammatory signaling molecules. Studies indicate that gut-derived metabolites of walnut polyphenols, particularly urolithins, appear to be especially relevant to these effects, with preclinical cell and animal studies showing reductions in pro-inflammatory cytokines, microglial activation, and T cell signaling, while a computational study identified specific molecular targets through which ellagic acid may act. The body of evidence includes narrative and systematic reviews, two meta-analyses, and several laboratory and animal studies, most pointing in a supportive direction, though a 2022 review specifically focused on neuroinflammation noted that human clinical evidence remains limited and inconclusive, and most mechanistic findings have not yet been replicated in rigorous human trials. One included study was a clinical case report unrelated to walnuts specifically, and overall, while the existing research is promising and consistent in direction, stronger randomized controlled trial evidence in humans is needed before firm conclusions can be drawn about the magnitude or clinical significance of walnuts' anti-inflammatory effects.